NASDAQ:HOLX

Hologic (HOLX) Stock Forecast, Price & News

$69.40

-0.65 (-0.93%)

(As of 09/29/2023 08:53 PM ET)

Compare

Today's Range: $69.29
▼
$70.34
50-Day Range: $69.24
▼
$81.90
52-Week Range: $59.78
▼
$87.88

Volume: 1.81 million shs
Average Volume: 1.60 million shs
Market Capitalization: $17.00 billion

P/E Ratio: 35.96
Dividend Yield: N/A
Price Target: $88.92

Hologic MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.57 Rating Score
Upside/Downside: 28.1% Upside
$88.92 Price Target
Short Interest: Healthy
2.26% of Float Sold Short
Dividend Strength: N/A
Sustainability: -1.41
Upright™ Environmental Score
News Sentiment: 0.84
Based on 11 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 1.79%
From $3.92 to $3.99 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.83 out of 5 stars

Medical Sector

66th out of 968 stocks

X - Ray Apparatus & Tubes Industry

1st out of 1 stocks

4.3

Analyst's Opinion

Consensus Rating
Hologic has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on 8 buy ratings, 6 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $88.92, Hologic has a forecasted upside of 28.1% from its current price of $69.40.
Amount of Analyst Coverage
Hologic has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

3.0

Short Interest

Percentage of Shares Shorted
2.26% of the float of Hologic has been sold short.
Short Interest Ratio / Days to Cover
Hologic has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Hologic has recently increased by 17.17%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Hologic does not currently pay a dividend.
Dividend Growth
Hologic does not have a long track record of dividend growth.

4.3

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Hologic has received a 65.16% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "HPV test kits", "3d ultrasound imaging software", "Ultrasound machines", "Private breast cancer diagnostics services", "Blood concentration quick tests", and "Mammography machines" products. See details.
Environmental Sustainability
The Environmental Impact score for Hologic is -1.41.

2.7

News and Social Media Coverage

News Sentiment
Hologic has a news sentiment score of 0.84. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.69 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 11 news articles for Hologic this week, compared to 6 articles on an average week.
Search Interest
Only 1 people have searched for HOLX on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added Hologic to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Hologic insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 1.66% of the stock of Hologic is held by insiders.
Percentage Held by Institutions
92.64% of the stock of Hologic is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Hologic are expected to grow by 1.79% in the coming year, from $3.92 to $3.99 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Hologic is 35.96, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 108.59.
Price to Earnings Ratio vs. Sector
The P/E ratio of Hologic is 35.96, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 94.18.
Price to Book Value per Share Ratio
Hologic has a P/B Ratio of 3.55. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Hologic (NASDAQ:HOLX) Stock

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalovirus; Aptima BV and Aptima CV/TV assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment, such as 2D and 3D digital mammography systems, image analytics software, reading workstations, ultrasound imaging, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and ultrasound and connectivity solutions, as well as breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology in the uterus; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; and the CoolSeal portfolio that includes bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

HOLX Price History

30 days | 90 days | 365 days | Advanced Chart

HOLX Stock News Headlines

October 2, 2023 | americanbankingnews.com

Hologic (NASDAQ:HOLX) and Iris BioTechnologies (OTCMKTS:IRSB) Critical Comparison

September 30, 2023 | finance.yahoo.com

Slowing Rates Of Return At Hologic (NASDAQ:HOLX) Leave Little Room For Excitement

October 2, 2023 | Wall Street Fundamentals (Ad)

How is This "Hidden Gem" Thriving in a Turbulent Market?

While Wall Street flounders and giants like Amazon & Microsoft lay off thousands... One overlooked company has been quietly achieving over 400% growth. How? By buying, building, and scaling a portfolio of promising brands in high-margin, recession-resistant verticals.

September 29, 2023 | finance.yahoo.com

Hologic to Expand Outreach During Breast Cancer Awareness Month

September 29, 2023 | americanbankingnews.com

Hologic, Inc. (NASDAQ:HOLX) Given Average Recommendation of "Moderate Buy" by Brokerages

September 22, 2023 | finance.yahoo.com

Nanaz Mohtashami Elected to Hologic Board of Directors

September 21, 2023 | marketwatch.com

Hologic Inc. stock falls Thursday, underperforms market

September 21, 2023 | finance.yahoo.com

Hologic and Bayer Announce International Partnership to Deliver Comprehensive Contrast-Enhanced Mammography Package to Breast Imaging Facilities

October 2, 2023 | Wall Street Fundamentals (Ad)

How is This "Hidden Gem" Thriving in a Turbulent Market?

September 13, 2023 | seekingalpha.com

Hologic: Post-Covid World Proving To Be A Nuisance On Profitability (Rating Downgrade)

September 11, 2023 | finance.yahoo.com

Jennifer Meade Named President at Aldevron

August 31, 2023 | finance.yahoo.com

Why Is Penumbra (PEN) Down 2.1% Since Last Earnings Report?

August 30, 2023 | finance.yahoo.com

Hologic, Inc. (NASDAQ:HOLX) Shares Could Be 25% Below Their Intrinsic Value Estimate

August 30, 2023 | markets.businessinsider.com

RBC Capital Sticks to Its Hold Rating for Hologic (HOLX)

August 28, 2023 | thestreet.com

Hologic (HOLX) Stock Advances, Joining S&P 500

August 21, 2023 | finance.yahoo.com

Is Hologic (HOLX) Modestly Overvalued? A Comprehensive Valuation Analysis

August 15, 2023 | marketwatch.com

Hologic Inc. stock underperforms Tuesday when compared to competitors

August 4, 2023 | finance.yahoo.com

Hologic, Inc. (NASDAQ:HOLX) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

August 2, 2023 | msn.com

RBC Capital Maintains Hologic (HOLX) Sector Perform Recommendation

August 2, 2023 | msn.com

Raymond James Maintains Hologic (HOLX) Outperform Recommendation

August 2, 2023 | markets.businessinsider.com

Hologic (HOLX) Receives a Buy from Mizuho Securities

August 1, 2023 | msn.com

Hologic Stock Falls After Q3 Revenue Dip, But It Lifts Revenue and Profit Outlook

August 1, 2023 | finance.yahoo.com

Hologic (HOLX) Tops Q3 Earnings and Revenue Estimates

August 1, 2023 | finance.yahoo.com

Hologic (HOLX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

July 31, 2023 | markets.businessinsider.com

Hologic Inc Q3 Earnings Summary

July 31, 2023 | msn.com

Hologic stock falls nearly 4% after company’s revenue drop on lower COVID-related sales

July 31, 2023 | finance.yahoo.com

Hologic Announces Financial Results for Third Quarter of Fiscal 2023

See More Headlines

Receive HOLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hologic and its competitors with MarketBeat's FREE daily newsletter.

HOLX Company Calendar

Last Earnings: 7/31/2023
Today: 10/02/2023
Next Earnings (Estimated): 10/30/2023
Fiscal Year End: 9/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Medical Instruments & Supplies
Sub-Industry: Health Care Equipment
Sector: Medical
Current Symbol: NASDAQ:HOLX
CUSIP: 43644010
CIK: 859737
Web: www.hologic.com
Phone: (508) 263-2900
Fax: 781-890-8031
Employees: 6,944
Year Founded: 1985

Price Target and Rating

Average Stock Price Forecast: $88.92
High Stock Price Forecast: $105.00
Low Stock Price Forecast: $70.00
Forecasted Upside/Downside: +28.1%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.57
Research Coverage: 14 Analysts

Profitability

EPS (Most Recent Fiscal Year): $1.93
Trailing P/E Ratio: 35.96
Forward P/E Ratio: 17.70
P/E Growth: N/A
Net Income: $1.30 billion
Net Margins: 11.99%
Pretax Margin: 16.69%
Return on Equity: 19.02%
Return on Assets: 10.47%

Debt

Debt-to-Equity Ratio: 0.54
Current Ratio: 4.42
Quick Ratio: 3.73

Sales & Book Value

Annual Sales: $4.86 billion
Price / Sales: 3.50
Cash Flow: $7.84 per share
Price / Cash Flow: 8.85
Book Value: $19.53 per share
Price / Book: 3.55

Miscellaneous

Outstanding Shares: 244,940,000
Free Float: 240,876,000
Market Cap: $17.00 billion
Optionable: Optionable
Beta: 1.01

Social Links

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

Mr. Stephen P. MacMillan (Age 59)
Chairman, CEO & Pres
Comp: $4.24M

Ms. Karleen M. Oberton (Age 52)
Chief Financial Officer
Comp: $1.58M

Mr. John M. Griffin (Age 62)
Gen. Counsel
Comp: $1.47M

Mr. Jan Verstreken (Age 55)
Group Pres of International
Comp: $1.24M

Mr. Paul Malenchini
Chief Information Officer

Ryan M. Simon
VP of Investor Relations

Ms. Elisabeth A. Hellmann (Age 54)
Sr. VP of Global HR & Corp. Communications

Ms. Monica Aguirre Berthelot
VP & Chief of Staff

Mr. Patrick Brady
Sr. VP of Global Supply Chain, Quality & Regulatory

Mr. Erik Anderson (Age 41)
Division Pres of Breast & Skeletal Health Solutions

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

HOLX Stock - Frequently Asked Questions

Should I buy or sell Hologic stock right now?: 14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hologic in the last year. There are currently 6 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" HOLX shares.
View HOLX analyst ratings or view top-rated stocks.
What is Hologic's stock price forecast for 2023?: 14 analysts have issued 12 month price objectives for Hologic's stock. Their HOLX share price forecasts range from $70.00 to $105.00. On average, they anticipate the company's share price to reach $88.92 in the next year. This suggests a possible upside of 28.1% from the stock's current price.
View analysts price targets for HOLX or view top-rated stocks among Wall Street analysts.
How have HOLX shares performed in 2023?: Hologic's stock was trading at $74.81 at the beginning of 2023. Since then, HOLX shares have decreased by 7.2% and is now trading at $69.40.
View the best growth stocks for 2023 here.
Are investors shorting Hologic?: Hologic saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 5,460,000 shares, an increase of 17.2% from the August 31st total of 4,660,000 shares. Based on an average daily volume of 1,730,000 shares, the short-interest ratio is presently 3.2 days. Currently, 2.3% of the shares of the company are sold short.
View Hologic's Short Interest.
When is Hologic's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, October 30th 2023.
View our HOLX earnings forecast.
How were Hologic's earnings last quarter?: Hologic, Inc. (NASDAQ:HOLX) issued its earnings results on Monday, July, 31st. The medical equipment provider reported $0.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.04. The medical equipment provider earned $984.40 million during the quarter, compared to analyst estimates of $960.22 million. Hologic had a trailing twelve-month return on equity of 19.02% and a net margin of 11.99%. The company's quarterly revenue was down 1.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.95 EPS.
Read the conference call transcript.
What ETFs hold Hologic's stock?: ETFs with the largest weight of Hologic (NASDAQ:HOLX) stock in their portfolio include OneAscent Large Cap Core ETF (OALC), VictoryShares THB Mid Cap ESG ETF (MDCP), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), VictoryShares Nasdaq Next 50 ETF (QQQN), SEI Enhanced U.S. Large Cap Quality Factor ETF (SEIQ), Fidelity Women's Leadership ETF (FDWM), First Trust Indxx Medical Devices ETF (MDEV) and iShares U.S. Medical Devices ETF (IHI).
What guidance has Hologic issued on next quarter's earnings?: Hologic issued an update on its FY23 earnings guidance on Monday, July, 31st. The company provided earnings per share guidance of $3.87-$3.94 for the period, compared to the consensus estimate of $3.91. The company issued revenue guidance of $3.995-$4.035 billion, compared to the consensus revenue estimate of $4.01 billion.

What is Steve MacMillan's approval rating as Hologic's CEO?: 447 employees have rated Hologic Chief Executive Officer Steve MacMillan on Glassdoor.com. Steve MacMillan has an approval rating of 79% among the company's employees. 81.0% of employees surveyed would recommend working at Hologic to a friend.
What other stocks do shareholders of Hologic own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Hologic investors own include AbbVie (ABBV), NVIDIA (NVDA), Johnson & Johnson (JNJ), Alibaba Group (BABA), Walt Disney (DIS), PayPal (PYPL), Advanced Micro Devices (AMD), CVS Health (CVS), Pfizer (PFE) and Abbott Laboratories (ABT).
What is Hologic's stock symbol?: Hologic trades on the NASDAQ under the ticker symbol "HOLX."
How do I buy shares of Hologic?: Shares of HOLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Hologic's stock price today?: One share of HOLX stock can currently be purchased for approximately $69.40.
How much money does Hologic make?: Hologic (NASDAQ:HOLX) has a market capitalization of $17.00 billion and generates $4.86 billion in revenue each year. The medical equipment provider earns $1.30 billion in net income (profit) each year or $1.93 on an earnings per share basis.
How many employees does Hologic have?: The company employs 6,944 workers across the globe.
Does Hologic have any subsidiaries?: The following companies are subsidiares of Hologic: Acessa Health, Acessa Health Inc., Beijing Hologic Technology Co. Ltd., Benassar Diagnostica-Equipamientos Medicos Unipessoal Lda., BioLucent, BioLucent LLC, Bioptics Inc., Biotheranostics Inc, Biotheranostics Inc., Bolder Surgical, Cynosure, Cytyc, Cytyc Corporation, Cytyc Prenatal Products Corp., Cytyc Surgical Products LLC, Diagenode Co. Ltd., Diagenode LLC, Diagenode SA, Diagenode SA., Diagenode SPA, Direct Radiography Corp., Emsor Sociedad de responsabilidad limitada, Faxitron Bioptics, Faxitron Bioptics LLC, Focal Therapeutics, Gen-Probe, Gen-Probe Incorporated, Gen-Probe Prodesse Inc., Gen-Probe Sales & Service Inc., Genewave SAS, Health Beacons Inc, Health Beacons Inc., Hologic (Australia & New Zealand) Pty Ltd., Hologic (MA) LLC, Hologic (Shanghai) Medical Supplies Co. Ltd., Hologic ASE LLC, Hologic Asia Limited, Hologic Asia Pacific Limited, Hologic Austria GmbH, Hologic BV, Hologic Bermuda Limited, Hologic Canada ULC, Hologic Caribbean (Barbados) SRL, Hologic Denmark ApS, Hologic Deutschland GmbH, Hologic Espana S.A., Hologic Finance Ltd., Hologic France SARL, Hologic GGO 2 LLC, Hologic GGO 3 LLP, Hologic GGO 4 LTD, Hologic Global Holding LTD, Hologic HUB LTD, Hologic Hitec-Imaging, Hologic Hitec-Imaging GmbH, Hologic Holdings Limited, Hologic IP LTD, Hologic Iberia S.L., Hologic India LLP, Hologic International Holdings B.V., Hologic Ireland Limited, Hologic Italia S.r.l., Hologic Japan KK, Hologic Latin America (Servicos Em Marketing E Negocios) Ltda., Hologic Ltd., Hologic Malaysia SDN. BHD., Hologic Medical Technologies (Beijing) Co. Ltd., Hologic Medicor GmbH, Hologic Medicor Suisse GmbH, Hologic Netherlands B.V., Hologic Nordic Holdings Oy, Hologic Singapore Pte. Ltd, Hologic Suisse SA, Hologic Surgical Products Costa Rica S.R.L., Hologic Sweden AB, Hologic Taiwan Ltd., Hologic UK Finance Ltd., Hologic US Finance Co LLC, Interlace Medical, Mobidiag Oy, Mobidiag Oy., Mobidiag UK Ltd., NXT-Dx SCRL, Navigation Three Limited, R2 Technology, Sentinelle Medical, Somatex (HK) Limited, Somatex Medical Technologies GmbH, Somatex Medical Technologies GmbH., Somatex USA Inc., SuperSonic Imagine (Shanghai) Medical Devices Co. Ltd., SuperSonic Imagine GmbH, SuperSonic Imagine HK Ltd, SuperSonic Imagine Ltd, SuperSonic Imagine SA, SuperSonic Imagine Srl, Suros Surgical Systems, Suros Surgical Systems Inc., TCT International, TCT International Co. Ltd., Third Wave Technologies, and Tridaho LLC.
Read More
How can I contact Hologic?: Hologic's mailing address is 250 CAMPUS DRIVE, MARLBOROUGH MA, 01752. The official website for the company is www.hologic.com. The medical equipment provider can be reached via phone at (508) 263-2900, via email at michael.watts@hologic.com, or via fax at 781-890-8031.

This page (NASDAQ:HOLX) was last updated on 10/2/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial